KIAA1860, MAP / microtubule affinity regulating kinase 4, MAP / microtubule affinity regulating kinase 4L, MAP/microtubule affinity regulating kinase 4, MAP/microtubule affinity regulating kinase like 1, MAP/microtubule affinity-regulating kinase 4, MAP/microtubule affinity-regulating kinase-like 1, MARK 4, MARK 4L, MARK L1, MARK4, MARK4 serine / threonine protein kinase, MARK4 serine/threonine protein kinase, MARK4_HUMAN, MARK4S, MARKL 1, MARKL1, Nbla00650, Putative protein product of Nbla00650
MARK4 is a member of the CAMKL family of protein kinases. Normally expressed in neural progenitors and is re-expressed in gliomas.
Applications
Suitable for use in Immunofluorescence/Immunocytochemistry, ELISA. Other applications not tested.
Recommended Dilution
Immunofluorescence (IF-IC): 1:100-1:500 ELISA (peptide): 1:20,000-1:40,000 Optimal dilutions to be determined by the researcher.
Storage and Stability
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Immunogen
Synthetic peptide corresponding to human MARK4.
Form
Supplied as a liquid in PBS, pH 7.4, 0.02% sodium azide, 50% glycerol.
Purity
Purified by immunoaffinity chromatography.
Specificity
Recognizes endogenous levels of human MARK4. Species Crossreactivity: Mouse
TDS
NCBI
UniProt
Tech Support
Customer Service
